Betaine and secondary events in an acute coronary syndrome cohort
- PMID: 22649561
- PMCID: PMC3359285
- DOI: 10.1371/journal.pone.0037883
Betaine and secondary events in an acute coronary syndrome cohort
Abstract
Background: Betaine insufficiency is associated with unfavourable vascular risk profiles in metabolic syndrome patients. We investigated associations between betaine insufficiency and secondary events in acute coronary syndrome patients.
Methods: Plasma (531) and urine (415) samples were collected four months after discharge following an acute coronary event. Death (34), secondary acute myocardial infarction (MI) (70) and hospital admission for heart failure (45) events were recorded over a median follow-up of 832 days.
Principal findings: The highest and lowest quintiles of urinary betaine excretion associated with risk of heart failure (p = 0.0046, p = 0.013 compared with middle 60%) but not with subsequent acute MI. The lowest quintile of plasma betaine was associated with subsequent acute MI (p = 0.014), and the top quintile plasma betaine with heart failure (p = 0.043), especially in patients with diabetes (p<0.001). Top quintile plasma concentrations of dimethylglycine (betaine metabolite) and top quintile plasma homocysteine both associated with all three outcomes, acute MI (p = 0.004, <0.001), heart failure (p = 0.027, p<0.001) and survival (p<0.001, p<0.001). High homocysteine was associated with high or low betaine excretion in >60% of these subjects (p = 0.017). Median NT-proBNP concentrations were lowest in the middle quintile of plasma betaine concentration (p = 0.002).
Conclusions: Betaine insufficiency indicates increased risk of secondary heart failure and acute MI. Its association with elevated homocysteine may partly explain the disappointing results of folate supplementation. In some patients, especially with diabetes, elevated plasma betaine also indicates increased risk.
Conflict of interest statement
Figures




Similar articles
-
Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study.PLoS One. 2014 Dec 10;9(12):e114969. doi: 10.1371/journal.pone.0114969. eCollection 2014. PLoS One. 2014. PMID: 25493436 Free PMC article.
-
Plasma lipids and betaine are related in an acute coronary syndrome cohort.PLoS One. 2011;6(7):e21666. doi: 10.1371/journal.pone.0021666. Epub 2011 Jul 1. PLoS One. 2011. PMID: 21747945 Free PMC article.
-
Variability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study.Cardiovasc Diabetol. 2012 Jul 11;11:34. doi: 10.1186/1475-2840-11-34. Cardiovasc Diabetol. 2012. PMID: 22510294 Free PMC article.
-
The contrasting relationships between betaine and homocysteine in two clinical cohorts are associated with plasma lipids and drug treatments.PLoS One. 2012;7(3):e32460. doi: 10.1371/journal.pone.0032460. Epub 2012 Mar 2. PLoS One. 2012. PMID: 22396767 Free PMC article.
-
Betaine: a key modulator of one-carbon metabolism and homocysteine status.Clin Chem Lab Med. 2005;43(10):1069-75. doi: 10.1515/CCLM.2005.187. Clin Chem Lab Med. 2005. PMID: 16197300 Review.
Cited by
-
High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study.J Clin Med. 2019 Nov 1;8(11):1813. doi: 10.3390/jcm8111813. J Clin Med. 2019. PMID: 31683780 Free PMC article.
-
Healthy Nordic diet and associations with plasma concentrations of metabolites in the choline oxidation pathway: a cross-sectional study from Northern Sweden.Nutr J. 2023 May 17;22(1):26. doi: 10.1186/s12937-023-00853-w. Nutr J. 2023. PMID: 37198607 Free PMC article.
-
Plasma Concentrations and Dietary Intakes of Choline and Betaine in Association With Atrial Fibrillation Risk: Results From 3 Prospective Cohorts With Different Health Profiles.J Am Heart Assoc. 2018 Apr 12;7(8):e008190. doi: 10.1161/JAHA.117.008190. J Am Heart Assoc. 2018. PMID: 29650710 Free PMC article.
-
Urea, TMAO, betaine and other osmolytes as endogenous diuretics in heart failure and hypertension.Heart Fail Rev. 2025 Sep;30(5):1061-1074. doi: 10.1007/s10741-025-10530-1. Epub 2025 Jun 2. Heart Fail Rev. 2025. PMID: 40455373 Free PMC article. Review.
-
Plasma dimethylglycine, nicotine exposure and risk of low bone mineral density and hip fracture: the Hordaland Health Study.Osteoporos Int. 2015 May;26(5):1573-83. doi: 10.1007/s00198-015-3030-4. Epub 2015 Jan 24. Osteoporos Int. 2015. PMID: 25616506
References
-
- Craig SAS. Betaine in human nutrition. Am J Clin Nutr. 2004;80:539–549. - PubMed
-
- Ueland PM, Holm PI, Hustad S. Betaine: a key modulator of one-carbon metabolism and homocysteine status. Clin Chem Lab Med. 2005;43:1069–1075. - PubMed
-
- Lever M, Slow S. The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Clin Biochem. 2010;43:732–744. - PubMed
-
- Ueland PM. Choline and betaine in health and disease. J Inherit Metab Dis. 2011;34:3–15. - PubMed
-
- Ratriyanto A, Mosenthin R, Bauer E, Eklund M. Metabolic, osmoregulatory and nutritional functions of betaine in monogastric animals. Asian-Austral J Animal Sci. 2009;22:1461–1476.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials